The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Amryt Pharma plc(NASDAQ:AMYT) 
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the compl...
Website: https://www.amrytpharma.com
Founded: 2004
Full Time Employees: 289
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Share this website to your friends
Amryt Pharma plc Days Payable Outstanding ttm (DPO)
Amryt Pharma plc Days Receivable Outstanding ttm (DSO)
Amryt Pharma plc Days Inventory Outstanding ttm (DIO)
Amryt Pharma plc Op Cashflow Per Share ttm
Amryt Pharma plc Free Cashflow Per Share ttm
Amryt Pharma plc Cash Per Share ttm
Amryt Pharma plc P/S ratio ttm
Amryt Pharma plc (GAAP) P/E ratio ttm
Amryt Pharma plc P/B ratio ttm
No extra charts and metrics for this ticker.